#ECHoS of Now, Breaking Through Cancer!
60 partners and 30 countries join forces in #echos, a solid foundation to develop EU to a global innovation hub for cancer! Great people gathered in Athens at 1st Greek Forum on Cancer. #Cancer mission Sofia Xesfingi Anabela Isidro Yasmin Faty Laura Motta Marius Geanta, MD Dr. Anita Gottlob Hellenic Cancer Federation | ELLOK Oslo Cancer Cluster Norges forskningsråd Kreftforeningen
Iain Foulkes shares an in-depth look into Cancer Grand Challenges, an initiative to redefine cancer research through innovation and collaboration. Nearly a decade ago, Cancer Research UK (CRUK) explored new funding models to tackle complex issues in cancer research. Inspired by initiatives like the XPRIZE and Gates Foundation’s Grand Challenges, Cancer Grand Challenges was born. With £200m invested across 11 teams and over 700 collaborators, this program encourages multi-disciplinary, global teams to tackle specific yet broad challenges. In 2020, they partnered with the National Cancer Institute (NCI), uniting the world’s largest cancer research funders. This #GrandChallenge changes the approach to funding and forms a social movement in scientific inquiry, opening avenues for high-risk, high-reward research. 🔗 https://lnkd.in/e2kK5SFN The initiative's challenge-led approach breaks traditional silos, enabling true innovation. It’s exciting to see how this model will continue to reshape the global research landscape!
📢 ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies organised its first #KnowledgeExchange event hosted by Sciensano, on April 15 and 16, 2024, in Brussels!! 🟢 The Knowledge Exchange programme is part of #ECHoS Work Package 2 and aims to facilitate the implementation of the Cancer Mission across various countries (Member States and countries associated with the #HorizonEurope program) by stimulating share of best practices and experiences within the network. Know more 👉 https://lnkd.in/dJF6mNqM #CancerMissionHubs #MissionCancer #HorizonEurope
Professor Translational Tumor Immunology and Head Immunotherapy Lab at VU medisch centrum
Important initiative from SITC: how can we make IO accessible on a global scale? Join the discussion!
Increasing Access to IO: A Global Webinar Series will focus on the nuances of applying the latest scientific and clinical advances in cancer immunotherapy around the globe. These events will provide a discussion forum for international attendees! Series Organizers: Ghassan Abou-Alfa, MD, MBA of Memorial Sloan Kettering Cancer Center, Jyoti Bajpai, MD, DM of Tata Memorial Centre, Ahmad Tarhini, MD, PhD of Moffitt Cancer Center, and Nora Sobrevilla, MD of Instituto Nacional de Cancerologia. Register for the entire series: https://lnkd.in/ghKX5y5y
#Facts and #Figures about #canSERV_EU💡 Did you know that every #cancer has a distinct cancer ribbon colour🎗️? For this reason, the canSERV colours are not randomly chosen, but feature 1️⃣2️⃣ distinct colours in a twist, each representing a specific type of cancer - including the 1️⃣0️⃣ most common cancers in Europe🌍 The twist also represents the close collaboration of world-class cancer research services on one platform to combine an extensive repertoire of technologies needed to advance cancer research. If you want to learn more about the canSERV project and our cancer research service catalogues, check www.canserv.eu
💥 Congratulations to the five research teams that have been chosen to tackle the most demanding challenges in the field of cancer research! ⚙ As part of #CRUK, we are determined to accelerate cancer discoveries. For 40 years scientists from academic universities and leading cancer centres have deposited their research tools with us. These range from antibodies, cell lines, organoids, small molecules, mouse models, cell culture media, proteins, vectors and other state-of- the-art technologies. ➡️ Click on the link below to learn more about the most recent funding round and get to know the teams. #cancertoolsorg #cancerresearch #lifesciences #cancergrandchallenges
Just announced: Cancer Grand Challenges awards a record £100m to five research teams to tackle cancer’s most complex problems. Read more: https://cruk.ink/4a2xkOp Cancer Grand Challenges is a global funding initiative (co-founded by us and the National Cancer Institute (NCI) in the US) to bring together a worldwide community of diverse, world-class research teams to think differently and help tackle the big questions facing cancer researchers. Click below to read more about the latest round of funding and to meet the teams! #CancerGrandChallenges #CancerResearch
MD PhD. Oncoplastic Breast Surgeon & Gyneacologic Surgeon at Hospital Clínic de Barcelona. Doctor of Medicine.
Should we reevaluate screening protocols?
NCI IN THE NEWS: For thirty years, there has been a gradual increase in cancer diagnoses among individuals under the age of 50 – and we don’t entirely know why. With numerous potential factors at play, uncovering the answer must be a top priority for cancer research. Both Cancer Research UK and the NCI have recognized this challenge, making it one of their nine shared research priorities as part of the Cancer Grand Challenges Initiative. Read more about this topic from the authors at New Scientist. Registration required. http://spr.ly/6049uL4TD
Co-Founder at WAVED Medical | Runway Startup Postdoc at Cornell Tech | NIH Principal Investigator
Research has shown the number of breast cancer diagnoses in younger women is increasing and I am glad to see that understanding the raise in cancer rates in younger individuals is one of the priorities for both the National Cancer Institute (NCI) and Cancer Research UK. #breastcancer #breastcancerresearch #cancerresearch
NCI IN THE NEWS: For thirty years, there has been a gradual increase in cancer diagnoses among individuals under the age of 50 – and we don’t entirely know why. With numerous potential factors at play, uncovering the answer must be a top priority for cancer research. Both Cancer Research UK and the NCI have recognized this challenge, making it one of their nine shared research priorities as part of the Cancer Grand Challenges Initiative. Read more about this topic from the authors at New Scientist. Registration required. http://spr.ly/6049uL4TD
Principal Consultant @ ECI Lifescience Consulting | Proteomics Expert | Precision Medicine Strategist | New Business Development
It is easier to see correlations than to determine the causality of diseases in a large population. Access to high quality data from molecular diagnosis and fit for purpose real world data will be critical to generate meaningful hypotheses for solving a health problem. #moleculardiagnostics #realworlddata #populationhealth
NCI IN THE NEWS: For thirty years, there has been a gradual increase in cancer diagnoses among individuals under the age of 50 – and we don’t entirely know why. With numerous potential factors at play, uncovering the answer must be a top priority for cancer research. Both Cancer Research UK and the NCI have recognized this challenge, making it one of their nine shared research priorities as part of the Cancer Grand Challenges Initiative. Read more about this topic from the authors at New Scientist. Registration required. http://spr.ly/6049uL4TD
